HRP20020971A2 - 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors - Google Patents
4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitorsInfo
- Publication number
- HRP20020971A2 HRP20020971A2 HR20020971A HRP20020971A HRP20020971A2 HR P20020971 A2 HRP20020971 A2 HR P20020971A2 HR 20020971 A HR20020971 A HR 20020971A HR P20020971 A HRP20020971 A HR P20020971A HR P20020971 A2 HRP20020971 A2 HR P20020971A2
- Authority
- HR
- Croatia
- Prior art keywords
- thiazo
- dihydro
- inhibitors
- ylamine derivatives
- ylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007396A FR2810036B1 (en) | 2000-06-09 | 2000-06-09 | 4,5-DIHYDRO-1,3-THIAZOL-2-YLAMINE DERIVATIVES, THEIR PREPARATION AND THE PHAMARCEUTICAL COMPOSITIONS CONTAINING THEM |
PCT/FR2001/001759 WO2001093867A1 (en) | 2000-06-09 | 2001-06-07 | 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20020971A2 true HRP20020971A2 (en) | 2005-02-28 |
Family
ID=8851133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20020971A HRP20020971A2 (en) | 2000-06-09 | 2002-12-06 | 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1299103B1 (en) |
JP (1) | JP4171297B2 (en) |
KR (1) | KR20030017990A (en) |
CN (1) | CN1441673A (en) |
AP (1) | AP2002002707A0 (en) |
AT (1) | ATE305298T1 (en) |
AU (2) | AU2001266123B2 (en) |
BR (1) | BR0111543A (en) |
CA (1) | CA2411572C (en) |
DE (1) | DE60113686T2 (en) |
DK (1) | DK1299103T3 (en) |
DZ (1) | DZ3366A1 (en) |
EA (1) | EA200300009A1 (en) |
EC (1) | ECSP024374A (en) |
ES (1) | ES2246327T3 (en) |
FR (1) | FR2810036B1 (en) |
HR (1) | HRP20020971A2 (en) |
HU (1) | HUP0300996A3 (en) |
IL (1) | IL153327A0 (en) |
MA (1) | MA25815A1 (en) |
MX (1) | MXPA02012072A (en) |
NO (1) | NO20025885L (en) |
NZ (1) | NZ522967A (en) |
OA (1) | OA12285A (en) |
PL (1) | PL360282A1 (en) |
WO (1) | WO2001093867A1 (en) |
ZA (1) | ZA200209770B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005063732A1 (en) * | 2003-12-23 | 2005-07-14 | Microbia, Inc. | Compounds and methods for the treatment of asthma |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1095710A (en) * | 1992-11-27 | 1994-11-30 | 惠尔康基金会集团公司 | Enzyme Inhibitors |
ES2129679T3 (en) * | 1993-10-21 | 1999-06-16 | Searle & Co | DERIVATIVES CONTAINING THE AMIDINO GROUP, USEFUL AS INHIBITORS OF NITRIC OXIDE SYNTHESES. |
AU4149696A (en) * | 1994-11-15 | 1996-06-06 | Merck & Co., Inc. | Substituted heterocycles as inhibitors of nitric oxide synthase |
-
2000
- 2000-06-09 FR FR0007396A patent/FR2810036B1/en not_active Expired - Fee Related
-
2001
- 2001-06-07 MX MXPA02012072A patent/MXPA02012072A/en active IP Right Grant
- 2001-06-07 DK DK01943579T patent/DK1299103T3/en active
- 2001-06-07 WO PCT/FR2001/001759 patent/WO2001093867A1/en active IP Right Grant
- 2001-06-07 AP APAP/P/2002/002707A patent/AP2002002707A0/en unknown
- 2001-06-07 KR KR1020027016786A patent/KR20030017990A/en not_active Application Discontinuation
- 2001-06-07 EA EA200300009A patent/EA200300009A1/en unknown
- 2001-06-07 IL IL15332701A patent/IL153327A0/en unknown
- 2001-06-07 CA CA002411572A patent/CA2411572C/en not_active Expired - Fee Related
- 2001-06-07 AU AU2001266123A patent/AU2001266123B2/en not_active Ceased
- 2001-06-07 EP EP01943579A patent/EP1299103B1/en not_active Expired - Lifetime
- 2001-06-07 JP JP2002501440A patent/JP4171297B2/en not_active Expired - Fee Related
- 2001-06-07 AT AT01943579T patent/ATE305298T1/en not_active IP Right Cessation
- 2001-06-07 OA OA1200200371A patent/OA12285A/en unknown
- 2001-06-07 DE DE60113686T patent/DE60113686T2/en not_active Expired - Lifetime
- 2001-06-07 AU AU6612301A patent/AU6612301A/en active Pending
- 2001-06-07 HU HU0300996A patent/HUP0300996A3/en unknown
- 2001-06-07 NZ NZ522967A patent/NZ522967A/en unknown
- 2001-06-07 DZ DZ013366A patent/DZ3366A1/en active
- 2001-06-07 BR BR0111543-0A patent/BR0111543A/en not_active Application Discontinuation
- 2001-06-07 PL PL36028201A patent/PL360282A1/en unknown
- 2001-06-07 ES ES01943579T patent/ES2246327T3/en not_active Expired - Lifetime
- 2001-06-07 CN CN01812587A patent/CN1441673A/en active Pending
-
2002
- 2002-12-02 ZA ZA200209770A patent/ZA200209770B/en unknown
- 2002-12-06 NO NO20025885A patent/NO20025885L/en not_active Application Discontinuation
- 2002-12-06 HR HR20020971A patent/HRP20020971A2/en not_active Application Discontinuation
- 2002-12-09 EC EC2002004374A patent/ECSP024374A/en unknown
- 2002-12-09 MA MA26940A patent/MA25815A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20030017990A (en) | 2003-03-04 |
NZ522967A (en) | 2005-07-29 |
ZA200209770B (en) | 2004-03-02 |
CA2411572C (en) | 2009-11-10 |
AP2002002707A0 (en) | 2002-12-31 |
JP4171297B2 (en) | 2008-10-22 |
NO20025885D0 (en) | 2002-12-06 |
BR0111543A (en) | 2003-07-01 |
EP1299103B1 (en) | 2005-09-28 |
CN1441673A (en) | 2003-09-10 |
IL153327A0 (en) | 2003-07-06 |
MA25815A1 (en) | 2003-07-01 |
CA2411572A1 (en) | 2001-12-13 |
FR2810036B1 (en) | 2004-04-23 |
DE60113686D1 (en) | 2006-02-09 |
NO20025885L (en) | 2003-01-29 |
EA200300009A1 (en) | 2003-04-24 |
EP1299103A1 (en) | 2003-04-09 |
JP2003535135A (en) | 2003-11-25 |
ES2246327T3 (en) | 2006-02-16 |
OA12285A (en) | 2006-05-12 |
HUP0300996A2 (en) | 2003-08-28 |
ATE305298T1 (en) | 2005-10-15 |
MXPA02012072A (en) | 2004-08-19 |
DE60113686T2 (en) | 2006-07-13 |
AU2001266123B2 (en) | 2007-01-25 |
DK1299103T3 (en) | 2006-01-23 |
WO2001093867A1 (en) | 2001-12-13 |
FR2810036A1 (en) | 2001-12-14 |
ECSP024374A (en) | 2003-02-06 |
HUP0300996A3 (en) | 2006-02-28 |
AU6612301A (en) | 2001-12-17 |
DZ3366A1 (en) | 2001-12-13 |
PL360282A1 (en) | 2004-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1047743A1 (en) | New use and novel n-azabicyclo-amide derivatives. | |
HK1048999A1 (en) | Azepinoindole derivatives, their preparation and use thereof | |
PT1296974E (en) | 2-cyanopyrrolidine derivatives and their use as medicaments | |
IL148545A0 (en) | Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof | |
IL156341A0 (en) | 1,5 benzothiazepines and their use as antihyperlipidemics | |
MXPA03004644A (en) | Phenylacetamido- pyrazole derivatives and their use as antitumor agents. | |
HUP0203961A3 (en) | 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicedes | |
IL156161A0 (en) | Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors | |
HK1081954A1 (en) | Novel 1,4-diazabicycloalkane derivatives, their preparation and use | |
AU2001275677A1 (en) | 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants | |
IL135451A0 (en) | 3-amino-3-arylpropan-1-ol derivatives, their preparation and use | |
MXPA03000644A (en) | Novel indole derivatives and their use as medicaments. | |
EP1210084A4 (en) | Pyridomorphinans, thienomoprhinans and use thereof | |
GB0026467D0 (en) | Compound, composition and use | |
MXPA03001826A (en) | Arylpiperazine derivatives and their use as psychotropic agents. | |
AU5464901A (en) | Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides | |
HUP0600238A3 (en) | Benzothiazole- and benzoxazole-4,7-dione derivatives and their use | |
GB0005301D0 (en) | Compound, composition and use | |
AU7815201A (en) | Synthetic salicylihalamides, apicularens and derivatives thereof | |
IL135452A0 (en) | 3-amino-3-arylpropan-1-ol derivatives, their preparation and use | |
HRP20020971A2 (en) | 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors | |
HUP0203678A3 (en) | Nitro-sulfobenzamide-derivatives, preparation and use thereof | |
HUP0203455A3 (en) | 2-arylquinoline derivatives, preparation and therautic use thereof | |
AU2001294910A1 (en) | 3-thioxo-(1,2,4)-oxadiazinan-5-one and their use as anti-antherosclerotic agents | |
AU7660601A (en) | Pseudo-metalloproteins, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20050519 Year of fee payment: 5 |
|
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
OBST | Application withdrawn |